The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma

Laryngoscope

Volumn 118, Issue 11, 2008, Pages 1970-1975

  Pan, Jianji ^a,d   Kong, Lin ^b   Lin, Senan ^a   Chen, Gang ^a   Chen, Qiang ^a   Lu, Jiade J ^b,c  

^a Medical University   (China)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Epidermal growth factor receptor; Nasopharyngeal carcinoma; Staging group; Vascular endothelial growth factor

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; VASCULOTROPIN; EPIDERMAL GROWTH FACTOR; TUMOR MARKER; VASCULOTROPIN A;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CELL MEMBRANE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; STAINING; BIOPSY; BIOSYNTHESIS; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GENETICS; HOSPITALIZATION; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RETROSPECTIVE STUDY;

BIOPSY; CYCLOOXYGENASE 2; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56149118365     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3181805134     Document Type: Article

References (22)

1. Cooper JS, Cohen R, Stevens RE. A comparison of staging system for nasopharyngeal carcinoma. Cancer 1998;83:213-219.
2. Ma J, Mai HQ, Hong MH, et al. Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations? Int J Radiat Oncol Biol Phys 2001;50:1181-1189.
3. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Path 2005;86:347-363.
4. Bentzen SM, Atasoy BM, Daley FM, et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 2005;23:5560-5567.
5. Hsu CH, Gao M, Chen CL, Yeh PY, Cheng AL. Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro. Oncology 2005;68:538-547.
6. Soo R, Putti T, Tao Q, et al. Over expression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Arch Otolaryngol Head Neck Surg 2005;131:147-152.
7. Murono S, Inoue H, Tanabe T, et al. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 2001;98:6905-6910.
8. Dannenberg AJ, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth, J Clin Invest 2000;105:1589-1594.
9. Jaeckel EC, Raja S, Tan J, et al. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor 8 with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2001;127:1253-1259.
10. Choe MS, Zhang X, Shin HJC, Shin DM, Chen ZG. Interaction between epidermal growth factor receptor and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer. Mol Cancer Ther 2005;4:1448-1455.
11. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. "
12. Krishna SM, James S, Balaram P. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res 2006;115:85-90.
13. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000;19:19-27.
14. Fosslien E. Molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 2001;31:325-348.
15. Kinoshita T, Takahashi Y, Sakashita T, Inoue H, Tanabe T, Yoshimoto T. Growth stimulation and induction of epidermal growth factor receptor by overproduction of cyclooxygenase 1 and 2 in human colon carcinoma cells. Biockim Biophys Acta 1999;438:120-130.
16. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 trans activates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002;8:289-293.
17. Dannenberg AJ, Altorki NK, Boyle JO, et al. Cyclooxygenase-2: a pharmacological target for the prevention of cancer. Lancet Oncol 2001;2:544-551.
18. Ferrandina G, Ranelletti FO, Lauriola L, et al. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer. Gynecol Oncol 2002;85:305-310.
19. Kim GE, Kim YB, Cho NH, et al. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival. Clin Cancer Res 2004;10:1366-1374.
20. von Rahden BHA, Stein HJ, Puhringer F, et al. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-c) in esophageal adenocarcinoma. Cancer Res 2005;65:5038-5044.
21. Huang GW, Masanori S, Li JE, et al. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope 2000;110:2066-2069.
22. Lo AK, Lo W, Tsao SW, et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 2006;8:173-180.